Abstract
Over recent years, the field of cell and gene therapy has witnessed rapid growth due to the demonstrated benefits of using living cells as therapeutic agents in a broad range of clinical studies and trials. Bioprocess economic models (BEMs) are fundamental tools for guiding decision-making in bioprocess design, being capable of supporting process optimization and helping to reduce production costs. These tools are particularly important when it comes to guiding manufacturing decisions and increasing the likelihood of market acceptance of cell-based therapies, which are often cost-prohibitive because of high resource and quality control costs. Not only this, but the inherent biological variability of their underlying bioprocesses makes them particularly susceptible to unforeseen costs arising from failed or delayed production batches. The present work reviews important concepts concerning the development of bioprocesses for stem cell therapy products and highlights the valuable role which BEMs can play in this endeavor. Additionally, some theoretical concepts relevant to the building and structuring of BEMs are explored. Finally, a comprehensive review of the existent BEMs so far reported in the scientific literature for stem cell-related bioprocesses is provided to showcase their potential usefulness.
Funder
Fundação para a Ciência e a Tecnologia
Programa Operacional Regional de Lisboa 2020
i4HB—Associate Laboratory Institute for Health and Bioeconomy
iBB—Institute for Bioengineering and Biosciences
Reference67 articles.
1. Cell therapies in the clinic;Wang;Bioeng. Transl. Med.,2021
2. Bone marrow transplantation: A historical review;Thomas;Medicina,2000
3. Cell therapy and the safety of embryonic stem cell-derived grafts;Hentze;Trends Biotechnol.,2007
4. Methods of induced pluripotent stem cells for clinical application;Seki;World J. Stem Cells,2015
5. Cell therapy for cartilage repair;Hulme;Emerg. Top. Life Sci.,2021
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献